Specific Marker Gene Analysis for Primary Central Nervous System Lymphoma Based on Methylation Difference and Development of Detection Primers
Brain and Behavior · 2025
DOI: 10.1002/brb3.70996 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Feng Yan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: DNA Methylation, Central Nervous System Neoplasms, Lymphoma. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation.
Abstract (Originalsprache)
Background
Primary central nervous system lymphoma (PCNSL) is a central nervous system disease with high mortality, wide variation in symptoms, and difficult diagnosis. The development of molecular markers for PCNSL is still in its initial stages.
Methods
The databases were analyzed by 450 K and RRBS, and the differential gene structure was displayed through Venn diagram, heatmap, and enrichment. ROC and survival curve analyses were performed on the marker genes. The specificity of PCNSL in blood samples of patients was verified by qPCR, and the sensitivity of the detection primers was verified by in vitro methylation and demethylation drug treatment cell experiments.
Results
Twenty‐six sites were identified using 450 K microarray analysis. The RRBS analysis team found 14,867 sites. The methylation site located in the promoter region of REHB was verified, and the results showed that the primers for this site were able to distinguish patients with PCNSL and were sensitive to the detection of methylation levels.
Conclusions
A pair of methylation primers targeting the RHEB promoter region were obtained, which demonstrated the potential to distinguish patients with PCNSL from those with other CNS diseases. These findings should be considered preliminary and serve as proof‐of‐concept for further validation in larger cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, China.
- China International Neuroscience Institute (China-INI), Beijing, China.
- China National Medical Center for Neurological Diseases, Beijing, China.
ORCID-Profile: Feng Yan
Förderung
- Beijing Natural Science Foundation
Zitieren
APA
Yan, F., Wang, Y., Fan, X., Wei, P., & Shan, Y. (2025). Specific Marker Gene Analysis for Primary Central Nervous System Lymphoma Based on Methylation Difference and Development of Detection Primers. Brain and Behavior. https://doi.org/10.1002/brb3.70996
Vancouver
Yan F, Wang Y, Fan X, Wei P, Shan Y. Specific Marker Gene Analysis for Primary Central Nervous System Lymphoma Based on Methylation Difference and Development of Detection Primers. Brain and Behavior. 2025. doi:10.1002/brb3.70996
BibTeX
@article{Yan2025,
author = {Yan, Feng and Wang, Yaming and Fan, Xiaotong and Wei, Penghu and Shan, Yongzhi},
title = {Specific Marker Gene Analysis for Primary Central Nervous System Lymphoma Based on Methylation Difference and Development of Detection Primers},
journal = {Brain and Behavior},
year = {2025},
doi = {10.1002/brb3.70996}
}
EUVIMED